Ovid Release: Company Names M.D., To Scientific Advisory Board Post author:Sam Post published:January 19, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 2 Underappreciated Biotech Stocks to Buy in 2018 January 1, 2018 LifeNet to Create Hundred of New Jobs in Virginia Through HQ Expansion August 17, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017